Research Article
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
Figure 1
Serum concentrations of sCD163. Serum sCD163 levels were measured by ELISA in overall group of patients with systemic sclerosis (SSc), patients with diffuse SSc (DcSSc), those with limited SSc (LcSSc) and controls. Symbols show individual patients; bars show the mean ± SEM. values were determined using Mann–Whitney U test.